Online citations, reference lists, and bibliographies.
← Back to Search

Platelet And Plasma Levels Of Glutamate And Glutamine In Migraine With And Without Aura

A. Cananzi, G. D'andrea, F. Perini, F. Zamberlan, K. Welch
Published 1995 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
We evaluated plasma and platelet glutamate and glutamine levels in migraine with and without aura during headache-free periods and compared the results with those of normal controls. The plasma and platelet levels of glutamine in migraine with and without aura were normal. Migraine without aura patients had higher glutamate levels in plasma, and normal platelet levels. In migraine with aura patients, glutamate levels were high in platelets, but not in plasma. This suggests different profiles of excitatory amino acid metabolism in migraine with and without aura.
This paper references
10.1016/S0021-9673(01)95500-1
Determination of amino acids in the brain by high-performance liquid chromatography with isocratic elution and electrochemical detection.
H. Zielke (1985)
Basic Mechanisms of Headache
J. Olesen (1988)
Glutamate. In: Lajtha A, editor. Handbook of neurochemistry. Metabolism in the nervous system
RP Shank (1983)
10.1016/S0733-8619(18)30319-0
The concept of migraine as a state of central neuronal hyperexcitability.
K. Welch (1990)
10.1111/j.1471-4159.1981.tb04502.x
Platelet Glutamate and Aspartate Uptake in Huntington's Disease
R. Mangano (1981)
Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society.
(1988)
10.1016/0022-510X(82)90245-3
Huntington's disease: Glutamate and aspartate metabolism in blood platelets
R. Mangano (1982)
10.1016/0009-8981(71)90433-5
Amino acid metabolism in uraemic patients.
J. Condon (1971)
10.1002/ANA.410190202
Glutamate and the pathophysiology of hypoxic–ischemic brain damage
S. Rothman (1986)
10.1177/0333102489009S1030
Low brain magnesium in migraine.
K. Welch (1989)
10.1212/WNL.40.10.1582
Neuroexcitatory plasma amino acids are elevated in migraine
M. Ferrari (1990)
10.1016/s0015-6264(80)80033-2
Glutamic acid : advances in biochemistry and physiology
L. J. Filer (1979)
10.1016/s0140-6736(69)90223-2
Migraine and epilepsy
J. Hernández-Gallego (1995)
10.1002/NEU.480150504
The nature of the chick's magnesium-sensitive retinal spreading depression
A. V. Harreveld (1984)
NMR spectroscopic and magnetoencephalographic studies in migraine with aura: support for the spreading depression hypothesis.
K. Welch (1992)
10.1016/0009-8981(80)90074-1
The distribution of amino acids between plasma and erythrocytes.
L. Hagenfeldt (1980)
10.1111/j.1526-4610.1988.hed2807477.x
Mitochondrial Abnormalities in Migraine. Preliminary Findings.
P. Montagna (1988)
Biochemistry of glutamate: glutamine and glutathione
A. Meister (1979)
10.1016/0049-3848(89)90118-7
Tyrosine platelet levels in normal subjects.
G. D'andrea (1989)
The distribution of aminoacids between plasma and erythrocytes
I Hagenveldt (1980)
10.1126/science.163.3869.826
Monosodium L-Glutamate: Its Pharmacology and Role in the Chinese Restaurant Syndrome
H. Schaumburg (1969)
10.1016/0378-4347(85)80052-9
Determination of neurotransmitter amino acids by high-performance liquid chromatography with fluorescence detection.
L. Zecca (1985)
10.1161/01.STR.20.2.299.A
Platelet levels of glutamate and aspartate in normal subjects.
G. D’Andrea (1989)
10.1055/S-0038-1646748
Regulation of carbohydrate metabolism in platelets. A review.
J. W. Akkerman (1978)
10.1111/j.1526-4610.1990.hed3007428.x
Magnetoencephalographic Studies of Migraine
G. Barkley (1990)
10.1111/j.1471-4159.1981.tb01701.x
The Human Platelet as a Model for the Glutamatergic Neuron: Platelet Uptake of L‐Glutamate
R. Mangano (1981)
10.1046/j.1468-2982.1991.1104197.x
Platelet Glycine, Glutamate and Aspartate in Primary Headache
G. D'andrea (1991)
Biochemistry of glutamate: glutamine and glutathione
A. Meister (1979)
10.1097/00008506-199507000-00014
Spreading depression of Leao in rodent and human cortex
R. S. McLachlan (1995)
10.1212/WNL.34.8.1059
Huntington's disease
J. Martin (1984)
Calcium mobility and glutamic acid release associated with EEG abnormality, migraine and epilepsy
N. van Gelder (1987)
10.1152/AJPLEGACY.1968.214.1.58
Uptake of amino acids by the human platelet.
P. Zieve (1968)



This paper is referenced by
10.1017/S1092852900018757
The link between glutamate and migraine.
N. Ramadan (2003)
TOPIRAMATE PROPHYLAXIS IN PATIENTS SUFFERING FROM MIGRAINE WITH AURA: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL *
F. Freitag (2003)
10.3389/fncom.2020.00004
Regulation of CSF and Brain Tissue Sodium Levels by the Blood-CSF and Blood-Brain Barriers During Migraine
Hamed Ghaffari (2020)
10.1038/sj.jcbfm.9600039
Increased Plasma Glutamate in Stroke Patients Might Be Linked to Altered Platelet Release and Uptake
A. Aliprandi (2005)
EFFICACY OF TOPIRAMATE IN MIGRAINE PROPHYLAXIS: A RANDOMIZED CONTROLLED STUDY *
S. Silberstein (2002)
10.1007/s101940170011
GABA and glutamate in migraine
G. D’Andrea (2001)
10.1007/s10072-015-2131-3
Biochemistry of primary headaches: role of tyrosine and tryptophan metabolism
G. D’Andrea (2015)
10.1016/j.neuroscience.2016.08.007
Monosodium glutamate alters the response properties of rat trigeminovascular neurons through activation of peripheral NMDA receptors
Melissa O'Brien (2016)
10.1186/s10194-016-0638-5
Altered kynurenine pathway metabolites in serum of chronic migraine patients
M. Curto (2016)
10.1111/j.1468-2982.2008.01749.x
Effective Prophylactic Treatments of Migraine Lower Plasma Glutamate Levels
A. Ferrari (2009)
10.1046/j.1468-2982.1997.1706652.x
Erythrocyte and Plasma Levels of Glutamate and Aspartate in Children Affected by Migraine
P. D’Eufemia (1997)
10.9778/cmajo.20170137
Association between salt substitutes/enhancers and changes in sodium levels in fast-food restaurants: a cross-sectional analysis.
Mary J. Scourboutakos (2018)
10.1016/j.pain.2009.09.031
Differences in short-term primary motor cortex synaptic potentiation as assessed by repetitive transcranial magnetic stimulation in migraine patients with and without aura
A. Conte (2010)
10.1016/j.jns.2013.12.022
SLC1A2 rs3794087 variant and risk for migraine
E. García-Martín (2014)
10.1007/s11739-015-1208-6
Fathoming the kynurenine pathway in migraine: why understanding the enzymatic cascades is still critically important
M. Curto (2015)
10.1007/s10072-004-0281-9
Preventive migraine therapy: what is new
A. Rapoport (2004)
10.1517/14656566.2013.806487
Activation of 5-hydroxytryptamine1B/1D/1F receptors as a mechanism of action of antimigraine drugs
Martha B. Ramírez Rosas (2013)
10.1016/j.brainres.2018.05.046
Role of glutamate and its receptors in migraine with reference to amitriptyline and transcranial magnetic stimulation therapy
G. Tripathi (2018)
10.1007/S11916-004-0049-1
Prophylactic migraine therapy: Emerging treatment options
M. Bigal (2004)
10.1159/000097971
Anger, Depression and Personality Dimensions in Patients with Migraine without Aura
G. Abbate-Daga (2007)
10.1016/S0072-9752(10)97026-7
Acute treatment of migraine.
J. Brandes (2010)
10.1155/1996/654071
Pathophysiology of Headaches with a Prominent Vascular Component
J. Pareja (1996)
10.1007/s10072-006-0579-x
Treatment of aura: solving the puzzle
G. D’Andrea (2006)
Migraines and mood disorders: nutritional and dietary intervention based on laboratory testing.
C. Nelson-Dooley (2009)
10.1111/j.1526-4610.2010.01669.x
The Lack of Peripheral Pathology in Migraine Headache
G. Lambert (2010)
10.1111/head.12240
Genome‐Wide‐Associated Variants in Migraine Susceptibility: A Replication Study From North India
J. Ghosh (2013)
10.2174/1381612822666151214105439
Tryptophan Catabolites and Migraine.
Zsuzsanna Bohár (2016)
10.1111/j.1526-4610.2010.01615.x
14th International Headache Congress: Clinical Highlights
T. Schwedt (2010)
10.1097/WNF.0b013e3181bf1dbe
Pregabalin in the Treatment of Chronic Migraine: An Open-Label Study
E. Calandre (2010)
10.1007/s10072-009-0074-2
Efficacy of Ginkgolide B in the prophylaxis of migraine with aura
G. D’Andrea (2009)
10.1111/j.1526-4610.2006.00708.x
The Influence of Gender and Sex Steroids on Craniofacial Nociception
B. Cairns (2007)
10.1007/s10072-004-0260-1
Contributions of biochemistry to the pathogenesis of primary headaches
G. D’Andrea (2004)
See more
Semantic Scholar Logo Some data provided by SemanticScholar